serum levels of tumor necrosis factor-α and interleukins in children with congenital heart disease
Authors
abstract
background: levels of anti-inflammatory cytokines in blood have a positive relationship with congenital heart disease (chd). we sought to assess the difference in serum cytokines levels between children with and without chd. methods: we recruited 60 patients with chd and 30 healthy children, from 2013 to 2014. patients with primary pulmonary hypertension; metabolic diseases; renal, endocrine, and chronic inflammatory diseases; fever; infection in the preceding 3 weeks; and malnutrition were excluded. participants’ demographic data were measured, and their cardiac diseases were diagnosed via echocardiography. serum levels of tumor necrosis factor (tnf)-α, interleukin (il)-6, and il-18 were measured via elisa. results: mean age of the participants was 4.28 ± 3.44, 3.12 ± 3.87 , and 3.30 ± 3.61 years in the cyanotic, acyanotic, and control groups, respectively (p value = 0.414). mean values of tnf-α (p value < 0.001), il-6 (p value < 0.001), il-18 (p value = 0.030), right ventricular pressure (p value < 0.001), and pulmonary pressure (p value = 0.015) were higher in the case group, while the bmi was higher in the controls (p value < 0.001). mean values of tnf-α (p value < 0.001), il-6 (p value < 0.001), and right ventricular pressure (p value < 0.001) were significantly higher in the cyanotic children, whereas the bmi was higher in the controls (p value < 0.001). levels of tnf-α and il-6 had significant correlations with right ventricular pressure. conclusion: the present study showed a differed serum cytokines levels between children with and without chd.
similar resources
Serum Levels of Tumor Necrosis Factor-α and Interleukins in Children with Congenital Heart Disease
Background: Levels of anti-inflammatory cytokines in blood have a positive relationship with congenital heart disease (CHD). We sought to assess the difference in serum cytokines levels between children with and without CHD. Methods: We recruited 60 patients with CHD and 30 healthy children, from 2013 to 2014. Patients with primary pulmonary hypertension; metabolic diseases; renal, endocrine, ...
full textEvaluation of Brain Natriuretic Peptide, Tumor Necrosis Factor and Interleukin-6 Plasma Levels in Infants and Children with Congenital Heart Disease
Background Congenital heart disease (CHD) is the most common cause of major congenital birth defect. The aim of this study was to investigate the association of CHD with serum levels of Tumor necrosis factor-α (TNFα), Interleukin 6 (IL-6), and B-type Natriuretic Peptide (BNP) in infant and children. Materials and Methods The present study was conducted in Heshmat heart hospital and 17 Shahrivar...
full textSerum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.
OBJECTIVE To estimate serum levels of ghrelin, tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in infants and children with congenital heart disease (CHD), compared with levels in age-matched controls, and to correlate the levels of ghrelin with TNF-alpha and IL-6. DESIGN Case-control study. SETTING Suzan Moubarak Hospital of Al-Minya University, Egypt. PATIENTS We measur...
full textPrognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
Background Heart failure (HF) in infants and children with congenital heart disease (CHD) is a crucial complication with different outcomes. Many biomarkers are used as prognostic indicators. Soluble ST2 (sST2) is one of these markers studied in adults with HF. We aimed to study the prognostic value of sST2 in CHD children with HF. Materials and Methods In current case-control study, thirty-six...
full text25-hydroxy Vitamin D Serum levels in Congenital Heart Disease (CHD) Children Compared to Controls
Background 25-hydroxy vitamin D [25(OH) VitD] deficiency is a highly prevalent condition, present in approximately 30% to 50% of the general population. A growing body of data suggests that low 25(OH) VitD levels may adversely affect cardiovascular health. The present study aimed to measure the serum levels of 25(OH) Vit D in Congenital heart disease (CHD) children compared to healthy children....
full textHigh Serum Levels of Rheumatoid Factor and Anti-Phosphatidylserine Antibody in Patients with Ischemic Heart Disease
Background: Immunopathological and inflammatory processes play important roles in the initiation and development of Ischemic Heart Disease (IHD). Objective: The aim of this study was to evaluate the serum levels of several autoantibodies including rheumatoid factor (RF), anti-nuclear antibodies (ANA), anti-small nuclear ribonucleoprotein (anti-Sm), anti-phosphatidylserine (anti-PS) and anti-car...
full textMy Resources
Save resource for easier access later
Journal title:
the journal of tehran university heart centerجلد ۱۲، شماره ۱، صفحات ۱۵-۲۲
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023